Molecular biology of malignant mesothelioma: A review

Hematology/Oncology Clinics of North America

Volumn 19, Issue 6, 2005, Pages 997-1023

  Pisick, Evan ^a   Salgia, Ravi ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BETA CATENIN; CYCLIN DEPENDENT KINASE; CYCLINE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN DICKKOPF 1; PROTEIN P14ARF; PROTEIN P16INK4A; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN; WNT PROTEIN;

CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CHROMOSOME 15; CHROMOSOME 6; CHROMOSOME 9; CHROMOSOME ABERRATION; GENE DELETION; GENETIC CODE; HUMAN; MALIGNANT MESOTHELIOMA; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS INFECTION;

CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MESOTHELIOMA; SIGNAL TRANSDUCTION;

EID: 28444448395     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.09.012     Document Type: Review

References (281)

1. H. Battifora, and W.T.E. McCaughey Tumors of the serosal membranes J. Rossi L.H. Sobin Atlas of tumor pathology 1995 Armed Forces Institute of Pathology Washington (DC) 17 99
2. J.R. Testa, H. Pass, and M. Carbone Molecular biology of mesothelioma V. DeVita S. Hellman S. Rosenberg Principles and practice of oncology 2001 JB Lippincott Philadelphia 1937 1943
3. M. Carbone, R.A. Kratzke, and J.R. Testa The pathogenesis of mesothelioma Semin Oncol 29 1 2002 2 17
4. J.C. Wagner, C.A. Sleggs, and P. Marchand Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br J Ind Med 17 1960 260 271
5. J.C. McDonald Health implications of environmental exposure to asbestos Environ Health Perspect 62 1985 319 328
6. J. Peto Continuing increase in mesothelioma mortality in Britain Lancet 345 8949 1995 535 539
7. M. Britton The epidemiology of mesothelioma Semin Oncol 29 1 2002 18 25
8. I.J. Selikoff, E.C. Hammond, and H. Seidman Mortality experience of insulation workers in the United States and Canada, 1943-1976 Ann NY Acad Sci 330 1979 91 116
9. B. Jarvholm, and A. Sanden Lung cancer and mesothelioma in the pleura and peritoneum among Swedish insulation workers Occup Environ Med 55 11 1998 766 770
10. B.T. Mossman Asbestos: scientific developments and implications for public policy Science 247 4940 1990 294 301
11. B.T. Mossman, and A. Churg Mechanisms in the pathogenesis of asbestosis and silicosis Am J Respir Crit Care Med 157 5 Pt 1 1998 1666 1680
12. W.J. Nicholson Comparative dose-response relationships of asbestos fiber types: magnitudes and uncertainties Ann NY Acad Sci 643 1991 74 84
13. R. Robledo, and B. Mossman Cellular and molecular mechanisms of asbestos-induced fibrosis J Cell Physiol 180 2 1999 158 166
14. G. Sluis-Kremer Asbestos disease at low exposures after long residence times Ann NY Acad Sci 643 1991 182 193
15. T. Ashcroft Epidemiological and quantitative relationships between mesothelioma and asbestos on Tyneside J Clin Pathol 26 11 1973 832 840
16. E. Hain Retrospective study of 150 cases of mesothelioma in Hamburg area Int Arch Arbeitsmed 33 1 1974 15 37
17. A.D. McDonald Epidemiology of primary malignant mesothelial tumors in Canada Cancer 26 4 1970 914 919
18. J. McEwen Mesothelioma in Scotland BMJ 4 735 1970 575 578
19. G.F. Rubino Epidemiology of pleural mesothelioma in Northwestern Italy (Piedmont) Br J Ind Med 29 4 1972 436 442
20. R.L. Zielhuis, J.P. Versteeg, and H.T. Planteijdt Pleura mesothelioma and exposure to asbestos: a retrospective case-control study in the Netherlands Int Arch Occup Environ Health 36 1 1975 1 18
21. J.C. McDonald Asbestos J.C. McDonald Epidemiology of work related diseases 2000 BMJ Books London 85 108
22. D. Coggon Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis Occup Environ Med 52 11 1995 775 777
23. J.L. Levin Tyler asbestos workers: mortality experience in a cohort exposed to amosite Occup Environ Med 55 3 1998 155 160
24. J.C. McDonald Mesothelioma and asbestos fiber type: evidence from lung tissue analyses Cancer 63 8 1989 1544 1547
25. H. Seidman, I.J. Selikoff, and E.C. Hammond Short-term asbestos work exposure and long-term observation Ann NY Acad Sci 330 1979 61 89
26. Y.I. Baris An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia Thorax 33 2 1978 181 192
27. L. Coplu An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos J Environ Pathol Toxicol Oncol 15 2-4 1996 177 182
28. A.N. Rohl Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey Science 216 4545 1982 518 520
29. I. Roushdy-Hammady Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey Lancet 357 9254 2001 444 445
30. S.S. Murthy, and J.R. Testa Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma J Cell Physiol 180 2 1999 150 157
31. Y.Y. Lu Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma Genes Chromosomes Cancer 9 1 1994 76 80
32. B.R. Seizinger Report of the committee on chromosome and gene loss in human neoplasia Cytogenetic Cell Genet 58 1991 1080 1096
33. K. Shigemitsu Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion Oncogene 20 31 2001 4249 4257
34. W.C. Lee Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma Cancer Res 56 19 1996 4297 4301
35. K. Offit 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma Blood 82 7 1993 2157 2162
36. V. Orphanos Allelic imbalance of chromosome 6q in ovarian tumours Br J Cancer 71 4 1995 666 669
37. Z.M. Sheng Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas Br J Cancer 73 2 1996 144 147
38. M.L. Cher Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping Cancer Res 56 13 1996 3091 3102
39. R.J. Osborne, and V. Leech Polymerase chain reaction allelotyping of human ovarian cancer Br J Cancer 69 3 1994 429 438
40. H. Tahara Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas Cancer Res 56 3 1996 599 605
41. W. Wick Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer Oncogene 12 5 1996 973 978
42. K.A. Heichman, and J.M. Roberts Rules to replicate by Cell 79 4 1994 557 562
43. J. Wuarin, and P. Nurse Regulating S phase: CDKs, licensing and proteolysis Cell 85 6 1996 785 787
44. D.O. Morgan Principles of CDK regulation Nature 374 6518 1995 131 134
45. K. Nasmyth Control of the yeast cell cycle by the Cdc28 protein kinase Curr Opin Cell Biol 5 2 1993 166 179
46. E.A. Nigg Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle Bioessays 17 6 1995 471 480
47. C. Norbury, and P. Nurse Animal cell cycles and their control Annu Rev Biochem 61 1992 441 470
48. S.I. Reed The role of p34 kinases in the G1 to S-phase transition Annu Rev Cell Biol 8 1992 529 561
49. C.J. Sherr Mammalian G1 cyclins Cell 73 6 1993 1059 1065
50. C.J. Sherr G1 phase progression: cycling on cue Cell 79 4 1994 551 555
51. M. Serrano, G.J. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 6456 1993 704 707
52. T. Nobori Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature 368 6473 1994 753 756
53. G.J. Hannon, and D. Beach p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest Nature 371 6494 1994 257 261
54. A. Kamb A cell cycle regulator potentially involved in genesis of many tumor types Science 264 5157 1994 436 440
55. K.L. Guan Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function Genes Dev 8 24 1994 2939 2952
56. H. Hirai Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 Mol Cell Biol 15 5 1995 2672 2681
57. F.K. Chan Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 Mol Cell Biol 15 5 1995 2682 2688
58. M.E. Ewen Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Cell 73 3 1993 487 497
59. S.F. Dowdy Physical interaction of the retinoblastoma protein with human D cyclins Cell 73 3 1993 499 511
60. J. Kato Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 Genes Dev 7 3 1993 331 342
61. S.J. Weintraub Mechanism of active transcriptional repression by the retinoblastoma protein Nature 375 6534 1995 812 815
62. S.J. Weintraub, C.A. Prater, and D.C. Dean Retinoblastoma protein switches the E2F site from positive to negative element Nature 358 6383 1992 259 261
63. P.A. Hamel Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene Mol Cell Biol 12 8 1992 3431 3438
64. E.K. Flemington, S.H. Speck, and W.G. Kaelin Jr E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product Proc Natl Acad Sci U S A 90 15 1993 6914 6918
65. E.W. Lam, and R.J. Watson An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription EMBO J 12 7 1993 2705 2713
66. J. Koh Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition Nature 375 6531 1995 506 510
67. J. Lukas Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity Mol Cell Biol 15 5 1995 2600 2611
68. J. Lukas Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 6531 1995 503 506
69. R.H. Medema Growth suppression by p16ink4 requires functional retinoblastoma protein Proc Natl Acad Sci U S A 92 14 1995 6289 6293
70. M. Serrano Inhibition of ras-induced proliferation and cellular transformation by p16INK4 Science 267 5195 1995 249 252
71. S.W. Tam Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with CDK4 is required for cyclin D1 function in G1 progression Oncogene 9 9 1994 2663 2674
72. M. Hatakeyama Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein Genes Dev 8 15 1994 1759 1771
73. P.W. Hinds Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Cell 70 6 1992 993 1006
74. S. Mittnacht Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation EMBO J 13 1 1994 118 127
75. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 3 1995 323 330
76. J. DeGregori, T. Kowalik, and J.R. Nevins Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes Mol Cell Biol 15 8 1995 4215 4224
77. R.J. Duronio, and P.H. O'Farrell Developmental control of the G1 to S transition in Drosophila: cyclin Eis a limiting downstream target of E2F Genes Dev 9 12 1995 1456 1468
78. Y. Geng Regulation of cyclin E transcription by E2Fs and retinoblastoma protein Oncogene 12 6 1996 1173 1180
79. D.G. Johnson, K. Ohtani, and J.R. Nevins Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression Genes Dev 8 13 1994 1514 1525
80. E. Neuman Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter Mol Cell Biol 14 10 1994 6607 6615
81. K. Ohtani, J. DeGregori, and J.R. Nevins Regulation of the cyclin E gene by transcription factor E2F1 Proc Natl Acad Sci U S A 92 26 1995 12146 12150
82. A. Schulze Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site Proc Natl Acad Sci U S A 92 24 1995 11264 11268
83. B.E. Clurman Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation Genes Dev 10 16 1996 1979 1990
84. K.A. Won, and S.I. Reed Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E EMBO J 15 16 1996 4182 4193
85. B.D. Dynlacht Differential regulation of E2F transactivation by cyclin/cdk2 complexes Genes Dev 8 15 1994 1772 1786
86. W. Krek Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase Cell 78 1 1994 161 172
87. W. Krek, G. Xu, and D.M. Livingston Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint Cell 83 7 1995 1149 1158
88. W.S. el-Deiry WAF1: a potential mediator of p53 tumor suppression Cell 75 4 1993 817 825
89. Y. Gu, C.W. Turck, and D.O. Morgan Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit Nature 366 6456 1993 707 710
90. J.W. Harper The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 4 1993 805 816
91. M.H. Lee, I. Reynisdottir, and J. Massague Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev 9 6 1995 639 649
92. S. Matsuoka p57KIP2, a structurally distinct member of the p21CIP1 CDK inhibitor family, is a candidate tumor suppressor gene Genes Dev 9 6 1995 650 662
93. A. Noda Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Exp Cell Res 211 1 1994 90 98
94. K. Polyak p27Kip1, a cyclin-CDK inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes Dev 8 1 1994 9 22
95. K. Polyak Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 1 1994 59 66
96. H. Toyoshima, and T. Hunter p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21 Cell 78 1 1994 67 74
97. Y. Xiong p21 is a universal inhibitor of cyclin kinases Nature 366 6456 1993 701 704
98. J. Nourse Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin Nature 372 6506 1994 570 573
99. J.Y. Kato Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation Cell 79 3 1994 487 496
100. D. Agrawal Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells Mol Cell Biol 16 8 1996 4327 4336
101. L. Hengst, and S.I. Reed Translational control of p27Kip1 accumulation during the cell cycle Science 271 5257 1996 1861 1864
102. M. Pagano Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 5224 1995 682 685
103. Y. Xiong, H. Zhang, and D. Beach Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation Genes Dev 7 8 1993 1572 1583
104. J. Jen Deletion of p16 and p15 genes in brain tumors Cancer Res 54 24 1994 6353 6358
105. S. Stone Genomic structure, expression and mutational analysis of the P15 (MTS2) gene Oncogene 11 5 1995 987 991
106. K.L. Guan Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4 Mol Biol Cell 7 1 1996 57 70
107. T. Okuda Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases Genomics 29 3 1995 623 630
108. D. Duro A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies Oncogene 11 1 1995 21 29
109. P. Jiang Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes p16 (MTS1) and p15 (MTS2) J Mol Evol 41 6 1995 795 802
110. L. Mao A novel p16INK4A transcript Cancer Res 55 14 1995 2995 2997
111. D.E. Quelle Cloning and characterization of murine p16INK4a and p15INK4b genes Oncogene 11 4 1995 635 645
112. S. Stone Complex structure and regulation of the P16 (MTS1) locus Cancer Res 55 14 1995 2988 2994
113. D.E. Quelle Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 6 1995 993 1000
114. M. Hall, S. Bates, and G. Peters Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins Oncogene 11 8 1995 1581 1588
115. D. Parry Lack of cyclin D-CDK complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product EMBO J 14 3 1995 503 511
116. A. Reymond, and R. Brent p16 proteins from melanoma-prone families are deficient in binding to CDK4 Oncogene 11 6 1995 1173 1178
117. H. Matsushime Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins Cell 71 2 1992 323 334
118. A. Sewing Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP J Cell Sci 104 Pt 2 1993 545 555
119. G.I. Shapiro Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines Cancer Res 55 24 1995 6200 6209
120. M. Ruas, and G. Peters The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim Biophys Acta 1378 2 1998 F115 F177
121. C.J. Sherr, and J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 10 1995 1149 1163
122. M.J. Kelley Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines J Natl Cancer Inst 87 10 1995 756 761
123. A. Merlo 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 7 1995 686 692
124. G.A. Otterson CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine Oncogene 11 6 1995 1211 1216
125. G.A. Otterson Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype Rb Oncogene 9 11 1994 3375 3378
126. G.I. Shapiro Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines Cancer Res 55 3 1995 505 509
127. T. Yeager Increased p16 levels correlate with pRb alterations in human urothelial cells Cancer Res 55 3 1995 493 497
128. T. Kamijo Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF Cell 91 5 1997 649 659
129. J. Pomerantz The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 Cell 92 6 1998 713 723
130. F.J. Stott The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 EMBO J 17 17 1998 5001 5014
131. W. Arap Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway Oncogene 15 17 1997 2013 2020
132. W.H. Liggett Jr p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro Cancer Res 56 18 1996 4119 4123
133. D.E. Quelle Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF Proc Natl Acad Sci U S A 94 2 1997 669 673
134. Y. Zhang, Y. Xiong, and W.G. Yarbrough ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 92 6 1998 725 734
135. J.Q. Cheng p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma Cancer Res 54 21 1994 5547 5551
136. T. Hirao Alterations of the p16(INK4) locus in human malignant mesothelial tumors Carcinogenesis 23 7 2002 1127 1130
137. S.P. Frizelle Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression Oncogene 16 24 1998 3087 3095
138. C.T. Yang Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells J Natl Cancer Inst 92 8 2000 636 641
139. P.M. Comoglio Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells EXS 65 1993 131 165
140. P.M. Comoglio, and C. Boccaccio The HGF receptor family: unconventional signal transducers for invasive cell growth Genes Cells 1 4 1996 347 354
141. M.F. Di Renzo Expression of the Met/HGF receptor in normal and neoplastic human tissues Oncogene 6 11 1991 1997 2003
142. F.M. Duh Gene structure of the human MET proto-oncogene Oncogene 15 13 1997 1583 1586
143. Y. Liu The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization Gene 215 1 1998 159 169
144. T. Seki Organization of the human hepatocyte growth factor-encoding gene Gene 102 2 1991 213 219
145. P.C. Ma c-Met: structure, functions and potential for therapeutic inhibition Cancer Metastasis Rev 22 4 2003 309 325
146. S. Artigiani, P.M. Comoglio, and L. Tamagnone Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals? IUBMB Life 48 5 1999 477 482
147. E. Maestrini A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor Proc Natl Acad Sci U S A 93 2 1996 674 678
148. L. Tamagnone Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates Cell 99 1 1999 71 80
149. L. Tamagnone, and P.M. Comoglio Signalling by semaphorin receptors: cell guidance and beyond Trends Cell Biol 10 9 2000 377 383
150. M. Tessier-Lavigne, and C.S. Goodman The molecular biology of axon guidance Science 274 5290 1996 1123 1133
151. P.M. Comoglio, L. Tamagnone, and C. Boccaccio Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth Exp Cell Res 253 1 1999 88 99
152. K. Nakashiro Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells Am J Pathol 157 3 2000 795 803
153. M.C. Stella, and P.M. Comoglio HGF: a multifunctional growth factor controlling cell scattering Int J Biochem Cell Biol 31 12 1999 1357 1362
154. I.S. Weimar Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34 +) Exp Hematol 26 9 1998 885 894
155. S. Yi Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines Br J Cancer 77 12 1998 2162 2170
156. S. Hayashi Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells Biochem Biophys Res Commun 220 3 1996 539 545
157. T. Iwazawa Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor Jpn J Cancer Res 87 11 1996 1134 1142
158. K. Takai Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis Blood 89 5 1997 1560 1565
159. K.A. Furge, Y.W. Zhang, and G.F. Vande Woude Met receptor tyrosine kinase: enhanced signaling through adapter proteins Oncogene 19 49 2000 5582 5589
160. A. Petrelli The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met Nature 416 6877 2002 187 190
161. J.H. Lee A novel germ line juxtamembrane Met mutation in human gastric cancer Oncogene 19 43 2000 4947 4953
162. M. Miller Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies Proteins 44 1 2001 32 43
163. L. Schmidt Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Nat Genet 16 1 1997 68 73
164. L. Schmidt Novel mutations of the MET proto-oncogene in papillary renal carcinomas Oncogene 18 14 1999 2343 2350
165. L. Schmidt Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene Cancer Res 58 8 1998 1719 1722
166. P. Peschard Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein Mol Cell 8 5 2001 995 1004
167. E. Tolnay Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma J Cancer Res Clin Oncol 124 6 1998 291 296
168. P. Harvey Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases Br J Cancer 83 9 2000 1147 1153
169. J. Klominek Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor Int J Cancer 76 2 1998 240 249
170. P. Cacciotti SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma Proc Natl Acad Sci U S A 98 21 2001 12032 12037
171. A. Catalano Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells J Biol Chem 279 45 2004 46706 46714
172. J.L. Villano A phase II trial of imatinib mesylate in patients (pts) with malignant mesothelioma (MM) J Clin Oncol 22 14S 2004 7200
173. Y. Ohta VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours Br J Cancer 81 1 1999 54 61
174. A. Catalano Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen Oncogene 21 18 2002 2896 2900
175. R.E. Krasnow, L.L. Wong, and P.N. Adler Dishevelled is a component of the frizzled signaling pathway in Drosophila Development 121 12 1995 4095 4102
176. U. Rothbacher Functional conservation of the Wnt signaling pathway revealed by ectopic expression of Drosophila dishevelled in Xenopus Dev Biol 170 2 1995 717 721
177. S.Y. Sokol Analysis of dishevelled signalling pathways during Xenopus development Curr Biol 6 11 1996 1456 1467
178. S.A. Steitz, M. Tsang, and D.J. Sussman Wnt-mediated relocalization of dishevelled proteins In Vitro Cell Dev Biol Anim 32 7 1996 441 445
179. S. Yanagawa The dishevelled protein is modified by wingless signaling in Drosophila Genes Dev 9 9 1995 1087 1097
180. R.H. Giles, J.H. van Es, and H. Clevers Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 1653 1 2003 1 24
181. B. Lustig, and J. Behrens The Wnt signaling pathway and its role in tumor development J Cancer Res Clin Oncol 129 4 2003 199 221
182. T.C. He Identification of c-MYC as a target of the APC pathway Science 281 5382 1998 1509 1512
183. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 6726 1999 422 426
184. S.M. Uthoff Wingless-type frizzled protein receptor signaling and its putative role in human colon cancer Mol Carcinog 31 1 2001 56 62
185. A. Wodarz, and R. Nusse Mechanisms of Wnt signaling in development Annu Rev Cell Dev Biol 14 1998 59 88
186. U. Wagner Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells FEBS Lett 411 2-3 1997 369 372
187. K. Uematsu Wnt pathway activation in mesothelioma: evidence of dishevelled overexpression and transcriptional activity of beta-catenin Cancer Res 63 15 2003 4547 4551
188. M. Boutros Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling Cell 94 1 1998 109 118
189. P.W. Finch Purification and molecular cloning of a secreted, frizzled-related antagonist of Wnt action Proc Natl Acad Sci U S A 94 13 1997 6770 6775
190. E. Hu Tissue restricted expression of two human Frzbs in preadipocytes and pancreas Biochem Biophys Res Commun 247 2 1998 287 293
191. A. Rattner A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors Proc Natl Acad Sci U S A 94 7 1997 2859 2863
192. A.Y. Lee Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma Oncogene 23 39 2004 6672 6676
193. M.V. Semenov Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 Curr Biol 11 12 2001 951 961
194. J.H. van Es, N. Barker, and H. Clevers You Wnt some, you lose some: oncogenes in the Wnt signaling pathway Curr Opin Genet Dev 13 1 2003 28 33
195. B. Mao Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling Nature 417 6889 2002 664 667
196. A.Y. Lee Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma Biochem Biophys Res Commun 323 4 2004 1246 1250
197. J. Mazieres Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer Cancer Res 64 14 2004 4717 4720
198. H. Suzuki Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 4 2004 417 422
199. C. Wissmann WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer J Pathol 201 2 2003 204 212
200. Z. Zhou Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors Int J Cancer 78 1 1998 95 99
201. M.T. Veeman, J.D. Axelrod, and R.T. Moon A second canon: functions and mechanisms of beta-catenin-independent Wnt signaling Dev Cell 5 3 2003 367 377
202. L. You Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells Cancer Res 64 10 2004 3474 3478
203. E.J. Brown A mammalian protein targeted by G1-arresting rapamycin-receptor complex Nature 369 6483 1994 756 758
204. M.I. Chiu, H. Katz, and V. Berlin RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex Proc Natl Acad Sci U S A 91 26 1994 12574 12578
205. D.M. Sabatini RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs Cell 78 1 1994 35 43
206. C.J. Sabers Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells J Biol Chem 270 2 1995 815 822
207. C.T. Keith, and S.L. Schreiber PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints Science 270 5233 1995 50 51
208. T. Schmelzle, and M.N. Hall TOR, a central controller of cell growth Cell 103 2 2000 253 262
209. A. Sekulic A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells Cancer Res 60 13 2000 3504 3513
210. M.A. Andrade, and P. Bork HEAT repeats in the Huntington's disease protein Nat Genet 11 2 1995 115 116
211. R. Bosotti, A. Isacchi, and E.L. Sonnhammer FAT: a novel domain in PIK-related kinases Trends Biochem Sci 25 5 2000 225 227
212. K. Hara Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism J Biol Chem 273 23 1998 14484 14494
213. G. Thomas, and M.N. Hall TOR signalling and control of cell growth Curr Opin Cell Biol 9 6 1997 782 787
214. H.B. Jefferies Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k EMBO J 16 12 1997 3693 3704
215. O. Meyuhas, D. Avni, and S. Shama Translational control of ribosomal protein mRNAs in eukaryotes J.W.B. Hershey M.B. Mathews N. Sonenberg Translational control 1996 Cold Spring Harbor Laboratory Press Cold Spring Harbor (NY) 363 388
216. G.J. Brunn The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus J Biol Chem 272 51 1997 32547 32550
217. N. Sonenberg, and A.C. Gingras The mRNA 5′ cap-binding protein eIF4E and control of cell growth Curr Opin Cell Biol 10 2 1998 268 275
218. R.J. White Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? Trends Biochem Sci 22 3 1997 77 80
219. P.B. Mahajan Modulation of transcription of rRNA genes by rapamycin Int J Immunopharmacol 16 9 1994 711 721
220. M. Leicht Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: involvement of the p70S6 kinase in the onset of protein and rRNA synthesis Cell Growth Differ 7 9 1996 1199 1209
221. S. Hashemolhosseini Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability J Biol Chem 273 23 1998 14424 14429
222. K. Yokogami Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR Curr Biol 10 1 2000 47 50
223. P. Cohen, D.R. Alessi, and D.A. Cross PDK1, one of the missing links in insulin signal transduction? FEBS Lett 410 1 1997 3 10
224. H. Dudek Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 5300 1997 661 665
225. R. Mendez Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase Mol Cell Biol 16 6 1996 2857 2864
226. S.R. von Manteuffel 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase Proc Natl Acad Sci U S A 93 9 1996 4076 4080
227. Z.M. Radisavljevic, and B. Gonzalez-Flecha TOR kinase and Ran are downstream from PI3K/Akt in H2O2-induced mitosis J Cell Biochem 91 6 2004 1293 1300
228. L. Dudkin Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition Clin Cancer Res 7 6 2001 1758 1764
229. M. Aoki, E. Blazek, and P.K. Vogt A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt Proc Natl Acad Sci U S A 98 1 2001 136 141
230. K. Podsypanina An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice Proc Natl Acad Sci U S A 98 18 2001 10320 10325
231. N.C. Barbet TOR controls translation initiation and early G1 progression in yeast Mol Biol Cell 7 1 1996 25 42
232. C.L. Zanella Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor Cancer Res 56 23 1996 5334 5338
233. J.L. Goldberg Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos Am J Respir Cell Mol Biol 17 3 1997 265 271
234. L.A. Jimenez Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2 Am J Physiol 273 5 Pt 1 1997 L1029 L1035
235. R. Seger, and E.G. Krebs The MAPK signaling cascade FASEB J 9 9 1995 726 735
236. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 270 28 1995 16483 16486
237. B. Su, and M. Karin Mitogen-activated protein kinase cascades and regulation of gene expression Curr Opin Immunol 8 3 1996 402 411
238. N.H. Heintz, Y.M. Janssen, and B.T. Mossman Persistent induction of c-fos and c-jun expression by asbestos Proc Natl Acad Sci U S A 90 8 1993 3299 3303
239. S.P. Faux Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres Carcinogenesis 21 12 2000 2275 2280
240. H. Sandhu mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats Carcinogenesis 21 5 2000 1023 1029
241. M.E. Ramos-Nino, C.R. Timblin, and B.T. Mossman Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression Cancer Res 62 21 2002 6065 6069
242. Y.M. Janssen-Heininger, M.E. Poynter, and P.A. Baeuerle Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB Free Radic Biol Med 28 9 2000 1317 1327
243. Y.M. Janssen Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells Proc Natl Acad Sci U S A 92 18 1995 8458 8462
244. M.I. Luster, and P.P. Simeonova Asbestos induces inflammatory cytokines in the lung through redox sensitive transcription factors Toxicol Lett 102-103 1998 271 275
245. P.P. Simeonova, and M.I. Luster Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation Am J Respir Cell Mol Biol 15 6 1996 787 795
246. K. Kahlos Generation of reactive oxygen species by human mesothelioma cells Br J Cancer 80 1-2 1999 25 31
247. V.L. Kinnula Manganese superoxide dismutase in human pleural mesothelioma cell lines Free Radic Biol Med 21 4 1996 527 532
248. I. Fridovich Superoxide dismutases Annu Rev Biochem 44 1975 147 159
249. K. Hirose Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation FASEB J 7 2 1993 361 368
250. Y.M. Janssen Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica J Biol Chem 267 15 1992 10625 10630
251. B.B. Warner Redox regulation of manganese superoxide dismutase Am J Physiol 271 1 Pt 1 1996 L150 L158
252. G.H. Wong, and D.V. Goeddel Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism Science 242 4880 1988 941 944
253. T. Nakano, K. Oka, and N. Taniguchi Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy Cancer Res 56 12 1996 2771 2775
254. B.K. Sinha, and E.G. Mimnaugh Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors Free Radic Biol Med 8 6 1990 567 581
255. K. Chang, and I. Pastan Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers Proc Natl Acad Sci U S A 93 1 1996 136 140
256. B.W. Robinson Mesothelin-family proteins and diagnosis of mesothelioma Lancet 362 9396 2003 1612 1616
257. E. Kettunen L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray Carcinogenesis 26 1 2005 17 25
258. R. Eckner Association of p300 and CBP with simian virus 40 large T antigen Mol Cell Biol 16 7 1996 3454 3464
259. T.D. Kierstead, and M.J. Tevethia Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations J Virol 67 4 1993 1817 1829
260. N.L. Lill p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen J Virol 71 1 1997 129 137
261. K.W. Peden Mutants with changes within or near a hydrophobic region of simian virus 40 large tumor antigen are defective for binding cellular protein p53 Virology 168 1 1989 13 21
262. A. Srinivasan, K.W. Peden, and J.M. Pipas The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions J Virol 63 12 1989 5459 5463
263. J. Zhu Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen J Virol 66 5 1992 2780 2791
264. T. Friedmann, R.F. Doolittle, and G. Walter Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences Nature 274 5668 1978 291 293
265. R. Goswami Effect of zinc ions on the biochemical behavior of simian virus 40 small-t antigen expressed in bacteria J Virol 66 3 1992 1746 1751
266. B. Turk Simian virus 40 small-t antigen binds two zinc ions J Virol 67 6 1993 3671 3673
267. N. Stewart, and S. Bacchetti Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells Virology 180 1 1991 49 57
268. I. Bikel SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen Cell 48 2 1987 321 330
269. J.A. Frost Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity Mol Cell Biol 14 9 1994 6244 6252
270. F. Tiemann, and W. Deppert Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency Oncogene 9 7 1994 1907 1915
271. B.E. Eddy Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40 Virology 17 1962 65 75
272. M. Carbone The role of small t antigen in SV40 carcinogenesis C. Nicolini Molecular basis of human cancer 1991 Plenum New York 191 206
273. C. Cicala, F. Pompetti, and M. Carbone SV40 induces mesotheliomas in hamsters Am J Pathol 142 5 1993 1524 1533
274. S.P. Kops Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents Anticancer Res 20 6C 2000 4745 4749
275. P. Rizzo Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection Cancer Res 59 24 1999 6103 6108
276. S.H. Ali, and J.A. DeCaprio Cellular transformation by SV40 large T antigen: interaction with host proteins Semin Cancer Biol 11 1 2001 15 23
277. M. Carbone New molecular and epidemiological issues in mesothelioma: role of SV40 J Cell Physiol 180 2 1999 167 172
278. B. Jasani Association of SV40 with human tumours Semin Cancer Biol 11 1 2001 49 61
279. G. Klein, A. Powers, and C. Croce Association of SV40 with human tumors Oncogene 21 8 2002 1141 1149
280. A. Hirvonen Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines Mol Carcinog 26 2 1999 93 99
281. F. Lopez-Rios Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids Lancet 364 9440 2004 1157 1166